Torrent Pharmaceuticals Ltd.
| BSE: 500420 | Sector: Health care |
| NSE: TORNTPHARM | ISIN Code: INE685A01028 |
| BSE 00:00 | 24 Apr 2020 | Torrent Pharmaceuticals Ltd |
| NSE 05:30 | 01 Jan 1970 | Torrent Pharmaceuticals Ltd |
Notice: Undefined property: stdClass::$market_capital_for_nse in /usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line 17
| OPEN | 2460.00 |
| PREVIOUS CLOSE | 2421.10 |
| VOLUME | 19349 |
| 52-Week high | 2679.45 |
| 52-Week low | 1453.00 |
| P/E | 44.01 |
| Mkt Cap.(Rs cr) | 41,148 |
| Buy Price | 2431.60 |
| Buy Qty | 1000.00 |
| Sell Price | 2450.00 |
| Sell Qty | 3.00 |
Torrent Pharmaceuticals Ltd. (TORNTPHARM) - News Sector
-
Strides Pharma gets DGCI approval to test potential Covid-19 drug
3.11 pm | 22 Dec 2020 | Business Standard
Glenmark was the first Indian firm to get approval from regulator to conduct trials on Favipiravir tablets, which are otherwise used to treat influenz...
-
How pandemic has brought changes in edtech sector
1.19 pm | 22 Dec 2020 | Business Standard
The Covid-19 crisis has been a major catalyst in enhancing the learning process not just for students and educators, but for investors as well
-
Coronavirus updates: India 4th worst hit; cases in 24 hours cross 10K-mark
4.18 pm | 7 Oct 2020 | Business Standard
The Delhi government is in the midst of yet another controversy as there have been discrepancies in the number of deaths reported by civic bodies and ...
-
Coronavirus updates: India 4th worst hit; cases in 24 hours cross 10K-mark
12.57 pm | 7 Oct 2020 | Business Standard
The Delhi government is in the midst of yet another controversy as there have been discrepancies in the number of deaths reported by civic bodies and ...
-
Kochi firm gets nod to test India's first novel molecule for Covid-19
5.16 pm | 11 Sep 2020 | Business Standard
PNB Vesper's drug developed from 12 years of research for small-cell lung cancer (for which it is under trial) has shown positive response in Covid-19...
-
India surpasses US, Brazil on 7-day average of daily new coronavirus cases
1.34 pm | 11 Sep 2020 | Business Standard
Singapore has announced $5.8 billion to extend a wage subsidy programme to next March, as most sectors continue to struggle amid the coronavirus pande...
-
From LAC to Aatmanirbhar Bharat, PM Modi's I-Day speech highlights in pics
5.17 pm | 1 Sep 2020 | Business Standard
The Red Fort lawns that remains filled to the brim on Independence Day, saw many vacant seats this year with the attendees wearing masks and maintaini...
-
All you need to know about Glenmark's Favipiravir, the potential Covid drug
2.12 pm | 22 Jun 2020 | Business Standard
The drug will be available in the Indian market under the brand name FabiFlu at Rs 103 per tablet
-
Biocon's Semglee, an insulin glargine injection, gets US FDA approval
9.36 am | 12 Jun 2020 | Business Standard
The Bengaluru-headquartered company also commits to provide affordable insulin at Rs 7 per day to lower and middle income countries as compared to Rs ...
-
Revised Wockhardt deal boosts prospects of Dr Reddy's India business
1.44 am | 12 Jun 2020 | Business Standard
The company, according to its new strategy, is focusing on growing its India-based branded products
-
Lupin recieves USFDA nod to market generic anthelmintic tablets
6.38 pm | 11 Jun 2020 | Business Standard
According to IQVIA MAT April 2020 data, Albendazole tablets had an annual sales of around $34 million in the US, Lupin said
-
Near-term hiccups to have limited impact on Abbott India's growth: Experts
12.51 pm | 11 Jun 2020 | Business Standard
Despite the muted result and near term worries, the multinational drug major, India's second largest by market share is expected to post strong growth...
-
Nifty Pharma gains 2.5%, crosses 10K mark for the 1st time since Oct 2018
11.49 am | 2 Jun 2020 | Business Standard
Aurobindo Pharma, Biocon, Cipla, and JB Chemicals & Pharmaceuticals hit their respective 52-week highs on the NSE on Tuesday.
-
Nifty view & stock calls by Anand Rathi: Buy Bharti Airtel, Cadila Health
7.58 am | 2 Jun 2020 | Business Standard
The stock of Bharti Airtel is making a higher top and higher bottom pattern on the daily chart and has formed a Doji candlestick pattern which hints o...
-
Biocon rallies 6%, hits record high on favourable ruling from US PTAB
3.12 pm | 1 Jun 2020 | Business Standard
Biocon's partner Mylan received a favourable ruling from U.S. Patent and Trademark Appeal Board (PTAB) on Sanofi's four device patents for Lantus Solo...
-
Stocks to watch: YES Bank, HCL Tech, IDBI Bank, aviation, Dilip Buildcon
9.20 am | 1 Jun 2020 | Business Standard
Here's a list of stocks that may remain in focus today
-
Top stock picks by CapitalVia Global Research: Buy RIL, Piramal Enterprises
8.12 am | 1 Jun 2020 | Business Standard
The level of 9,200 might act as a base for Nifty's weekly expiry
-
Once the stock breakout, wait for the rally to sustain with decent volumes
8.08 pm | 21 May 2020 | Business Standard
One needs to develop strategies that provide confirmation on
-
Confused about when to buy a stock? Here's what you need to know
6.35 pm | 21 May 2020 | Business Standard
One needs to first gauge the overall trend by correlating different indicators and chart patterns with price momentum.
-
ut raises doubts on the trading strategies. Subsequent triggers in the
6.17 pm | 21 May 2020 | Business Standard
ntify is the swings with volatile volumes s
Quick Links for Torrent Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
